Blackrock Neurotech, a leading platform for brain-computer interface (BCI) technology and manufacturing, has closed a $10 million financing round, led by Christian Angermayer's re.Mind Capital, with participation from Peter Thiel, German entrepreneur Tim Sievers, and Sorenson Impact's University Venture Fund II.

Blackrock Neurotech is dedicated to efforts in clinical translation and brain-computer interface (BCI) technology. Blackrock, founded in 2008, is a lading platform company for BCI technology for teams developing implantable solutions to improve human lives.